DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women

Phase 1

Completed

Conditions: Obesity

Interventions: Drug: Exenatide
Drug: Normal saline .2cc subcutaneous injection

First Posted Date: 2011-12-29

Last Posted Date: 2017-11-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 34

Registration Number: NCT01501084

Locations: 🇺🇸
UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress, Los Angeles, California, United States

eRT Remote Health Monitoring

Not Applicable

Completed

Conditions: Pulmonary Disease, Chronic Obstructive
COPD
Chronic Obstructive Lung Disease
Bronchitis, Chronic
Pulmonary Emphysema

Interventions: Behavioral: Remote Health Monitoring

First Posted Date: 2011-12-20

Last Posted Date: 2020-05-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 17

Registration Number: NCT01495780

Locations: 🇺🇸
UCLA David Geffen School of Medicine, Los Angeles, California, United States

Early Intervention for Youth at Risk for Bipolar Disorder

Not Applicable

Completed

Conditions: Bipolar Disorder
Major Depressive Disorder

Interventions: Behavioral: Family-Focused Treatment
Behavioral: Enhanced Care

First Posted Date: 2011-12-01

Last Posted Date: 2021-10-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 150

Registration Number: NCT01483391

Locations: 🇺🇸
UCLA Child and Adolescent Mood Disorders Program, UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, California, United States
🇺🇸
University of Colorado, Boulder, Boulder, Colorado, United States

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Phase 2

Conditions: Secondary-progressive Multiple Sclerosis
Primary-progressive Multiple Sclerosis
Relapsing-remitting Multiple Sclerosis

Interventions: Other: Placebo
Drug: estriol
Other: Progestin Placebo
Drug: Norethindrone

First Posted Date: 2011-11-06

Last Posted Date: 2019-11-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 64

Registration Number: NCT01466114

Locations: 🇺🇸
The University of Colorado Denver, Aurora, Colorado, United States
🇺🇸
The University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸
The University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 1 locations

Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM

Phase 1

Completed

Conditions: HIV

Interventions: Behavioral: Peer Navigator Intervention

First Posted Date: 2011-10-21

Last Posted Date: 2015-05-27

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 118

Registration Number: NCT01457066

Locations: 🇺🇸
AltaMed, Los Angeles, California, United States

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia (Recent-onset)

Interventions: Drug: paliperidone palmitate
Drug: risperidone

First Posted Date: 2011-10-14

Last Posted Date: 2022-04-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 146

Registration Number: NCT01451736

Locations: 🇺🇸
UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States

Q-Trial in Patients With Hepatitis C

Phase 1

Completed

Conditions: Chronic Hepatitis C

Interventions: Dietary Supplement: Quercetin

First Posted Date: 2011-09-22

Last Posted Date: 2015-03-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 34

Registration Number: NCT01438320

Locations: 🇺🇸
UCLA Jonsson Comprehensive Cancer Center. Factor Building, los Angeles, California, United States

Centralized Off-Site Adherence Enhancement Program

Not Applicable

Completed

Conditions: HIV/AIDS, Medication Adherence

Interventions: Behavioral: cognitive-behavioral therapy

First Posted Date: 2011-08-04

Last Posted Date: 2016-02-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 42

Registration Number: NCT01409655

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Family Focused Treatment of Pediatric Obsessive Compulsive Disorder

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Behavioral: Positive Family Interaction Therapy
Behavioral: Individual Child CBT

First Posted Date: 2011-08-04

Last Posted Date: 2021-05-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 62

Registration Number: NCT01409642

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care

Not Applicable

Completed

Conditions: HIV-infection/Aids

Interventions: Behavioral: Peer Navigator

First Posted Date: 2011-08-01

Last Posted Date: 2020-11-18

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 356

Registration Number: NCT01406626

Locations: 🇺🇸
LA County Jail, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy